METHOD OF ULCERATIVE COLITIS AND CROHN'S DISEASE THERAPY

摘要

FIELD: medicine. ^ SUBSTANCE: invention concerns medicine, particularly gastoenterology, and concerns treating ulcerative colitis and Crohn's disease. That is ensured by the oral introduction of the probiotic Bifiform in dose 2-3 capcules. It is followed by the 4-5-fold introduction of mesenchymal stem cells in number 150-200 mil. cells in 0.5 to 1.5 ml into a mucous membrane of changed intestinal segments. Further, Bifiform is introduced in dose 1 capsule 3 times a day for 3 weeks. ^ EFFECT: method provides higher clinical effectiveness in said diseases. ^ 3 ex